MedDataX Logo

Study of Inhaled Glucocorticosteroid Administration in Asthma Patients

NCT ID: NCT00559689

Last Updated: 2009-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

24 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-11-30

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Once-daily inhaled glucocorticosteroids treatment can sufficiently control airway inflammation in asthma patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients

NCT00627731

Asthma
COMPLETED PHASE4

Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients

NCT00855959

Asthma
COMPLETED PHASE3

A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

NCT00411567

Bronchial Asthma
COMPLETED PHASE1/PHASE2

Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma

NCT04503460

Asthma
UNKNOWN PHASE4

Does Inhaled Busedonide or Fluticasone Impair Adrenal Function?

NCT00560625

Adrenal Insufficiency
TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

receive once-daily administration of inhaled glucocorticosteroids at bedtime

Budesonide,hydrofluoroalkane-beclomethasone

Intervention Type DRUG

once-daily administration at bedtime

2

receive twice-daily administration of inhaled glucocorticosteroids

Budesonide,hydrofluoroalkane-beclomethasone dipropionate

Intervention Type DRUG

receive twice-daily administration

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Budesonide,hydrofluoroalkane-beclomethasone dipropionate

receive twice-daily administration

Intervention Type DRUG

Budesonide,hydrofluoroalkane-beclomethasone

once-daily administration at bedtime

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Receive ICS for one year or more, with no change in dose within the previous 8 weeks

Exclusion Criteria

* Two or more courses of oral corticosteroid in the previous 12 months
* Admission to hospital due to asthma in the previous 6 months
* Admission to the intensive care unit due to asthma at any time in the past
* Current cigarette smoker.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hamamatsu University

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kingo Chida, MD,PhD

Role: STUDY_CHAIR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hamamatsu University School of Medicine

Hamamatsu, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-17-43

Identifier Type: -

Identifier Source: secondary_id

Hamamatsu-17-43

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
NCT01400906 COMPLETED PHASE2
Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
NCT02105012 COMPLETED PHASE2
Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
NCT01431950 COMPLETED PHASE3
Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00504062 COMPLETED PHASE3
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
NCT00522782 COMPLETED PHASE4
Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
NCT00667992 COMPLETED PHASE3
Inhaled Steroid Treatment as Regular Therapy in Early Asthma
NCT00641914 COMPLETED PHASE4
A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
NCT01056159 COMPLETED PHASE1
Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
NCT02574975 UNKNOWN PHASE4
Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma
NCT02113436 COMPLETED PHASE4
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069 RECRUITING
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
NCT01479621 COMPLETED PHASE2
A Study of 2 Doses of MAP0010 in Adult Asthmatics
NCT00554970 COMPLETED PHASE2
A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
NCT00453778 COMPLETED PHASE4
Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
NCT00509028 COMPLETED PHASE3
Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma
NCT06940700 NOT_YET_RECRUITING PHASE2
Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?
NCT00509197 TERMINATED NA
A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
NCT01136382 COMPLETED PHASE2
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
NCT05417906 ACTIVE_NOT_RECRUITING PHASE2
Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
NCT01219738 COMPLETED NA
A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
NCT06502366 RECRUITING PHASE3
Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
NCT01436071 COMPLETED PHASE3
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
NCT01159912 COMPLETED PHASE3
Role of microRNAs in T Cell-Driven Inflammation in Asthma
NCT01484691 COMPLETED NA
Study to Assess Effect of Next-Generation Propellant MDI on Mucociliary Clearance Vs. HFA Propellant MDI in Healthy Participants
NCT05755932 COMPLETED PHASE3